---
$id: https://graph.org.ai/products/commodity/51142516
$type: Product
source: UNSPSC
code: "51142516"
title: "Tolcapone"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tolcapone

**UNSPSC Code**: 51142516
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent with the molecular formula C14H11NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CIF6334OLY, chemically known as 3,4-dihydroxy-4-methyl-5-nitrobenzophenone but generally known as tolcapone, which bears US NIH Compound Identifier 4659569. European Medicines Agency schedules Tolcapone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11151MIG. The term TOLCAPONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules tolcapone in its Anatomical Therapeutic Chemical (ATC) Classification. TOLCAPONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tolcapone under HS 29147000 and SITC 51629. As of Q4 2014, TOLCAPONE remains the US FDA Preferred Term for this commodity. Tolcapone bears US NLM identifiers UMLS ID C0246330 and NCI Concept Code C47762. SMILES: O=C(C1CC([N](=O)O)C(O)C(O)C1)C1CCC(CC1)C.

